Browse EX-10 agreements

ENGENE HOLDINGS INC.

AMENDED AND RESTATED 2023 EQUITY INCENTIVE PLAN

NONQUALIFIED STOCK OPTION GRANT AGREEMENT

This NONQUALIFIED STOCK OPTION GRANT AGREEMENT (the “Agreement”), dated as of [●] (the “Date of Grant”), is delivered by enGene Therapeutics Inc., a company organized under the laws of British Columbia, Canada and formerly known as enGene Holdings Inc. (the “Company”), to [●] (the “Participant”).

RECITALS

The enGene Holdings Inc. Amended and Restated 2023 Equity Incentive Plan (the “Plan”) provides for the grant of stock options to purchase common shares of the Company (“Company Shares”). The Committee has decided to make this nonqualified stock option grant as an inducement for the Participant to promote the best interests of the Company and its shareholders. This Agreement is made pursuant to the Plan and is subject in its entirety to all applicable provisions of the Plan. Capitalized terms used herein and not otherwise defined will have the meanings set forth in the Plan.

1.

…

Exhibit 10.1

INFORMATION IN THIS EXHIBIT IDENTIFIED BY [***] IS CONFIDENTIAL AND HAS BEEN EXCLUDED PURSUANT TO ITEM 601(B)(10)(iv) OF REGULATION S-K BECAUSE IT IS BOTH NOT MATERIAL AND CUSTOMARILY AND ACTUALLY TREATED BY THE REGISTRANT AS PRIVATE OR CONFIDENTIAL.

OTHER TRANSACTION AGREEMENT

BETWEEN

Rigetti & Co, LLC

775 Heinz Avenue, Berkeley, CA 94710

AND

United States Department of Commerce

1401 Constitution Avenue, NW, Washington, DC 20230

CONCERNING

ADVANCED MICROELECTRONICS RESEARCH AND DEVELOPMENT IN THE U.S.

FAIN:		80NANB26T203
Award Amount:		$100,000,000
Authorities:		15 U.S.C. § 4656(c)(2)(A)
		15 U.S.C. § 4659(a)(1)
Award Date:		September 4, 2026

…

SECURITIES ISSUANCE AGREEMENT

THIS SECURITIES ISSUANCE AGREEMENT (this “Agreement”), is made as of September 8, 2026, by and between Rigetti Computing, Inc., a Delaware corporation (the “Company”), and the United States Department of Commerce (the “Department”).

WHEREAS, the Department and Rigetti & Co, LLC, a wholly-owned subsidiary of the Company (the “Awardee”), are parties to that certain Other Transaction Agreement, dated September 4, 2026 (the “Award Agreement”), setting forth, among other things, certain terms and conditions pursuant to which the Department agreed to issue to the Awardee an award (the “Award”) administered pursuant to the CHIPS Act; and

WHEREAS, in order to induce the Department to enter into the Award Agreement, the Company has agreed, subject to the terms and conditions set forth herein, to issue to the Department such number of Shares (as defined below) set forth in Item 1 of Exhibit A.

…

June 17, 2026

Keith Lane

Dear Keith:

Kiara Pharmaceuticals, Inc. (the "Company'') is pleased to offer you employment with a start date of September 1, 2026 (the "Start Date"). Your role shall be to serve as Executive Vice President, Head of Clinical Development and Regulatory Affairs of the Company. This letter is intended to summarize some of the terms of your employment. We refer you to the policies, plans and practices of the Company for more details on the terms and conditions of your employment.

Your employment is considered "at will"; both you and the Company have the right to terminate your employment at any time for any reason. This letter does not constitute, and shall not be construed as, creating a contract or promise of employment for any set period of time.

…

Execution Copy FAIN: 80NANB26T200 Page 1 of 51 OTHER TRANSACTION AGREEMENT BETWEEN D-Wave Quantum Inc. 2650 E. Bayshore Road, Palo Alto, CA 94303 AND United States Department of Commerce 1401 Constitution Avenue, NW, Washington, DC 20230 CONCERNING ADVANCED MICROELECTRONICS RESEARCH AND DEVELOPMENT IN THE U.S. FAIN: 80NANB26T200 Award Amount: $100,000,000 Authorities: 15 U.S.C. § 4656(c)(2)(A) 15 U.S.C. § 4659(a)(1) 15 U.S.C. § 4656(d) Award Date: September 4, 2026 Pursuant to the Authorities specified above, this Other Transaction Agreement is entered into as of the Award Date specified above, between D-Wave Quantum Inc. (the “Awardee”) and the U.S. Department of Commerce (the “Department”). D-WAVE QUANTUM INC. UNITED STATES DEPARTMENT OF COMMERCE By: /s/ Alan Baratz By: /s/ Bill Frauenhofer Name: Alan Baratz Name: Bill Frauenhofer Title: Director Title: Executive Director Semiconductor Innovation and Investment Certain identified information has been excluded from the exhibit because it (i) is not material and (ii) is the type that the registrant treats as private or confidential.

…

---

Exhibit 10.1

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT by and between Anteris Technologies Global Corp., a Delaware corporation (the “Company”), and Brent Moen (“Executive”), is dated as of the 4th day of September, 2026 (this “Agreement”).

WHEREAS, the Company wishes to employ Executive on the terms and conditions, and for the consideration, hereinafter set forth, and Executive desires to be employed by the Company on such terms and conditions and for such consideration.

NOW, THEREFORE, in consideration of the promises provided for in this Agreement, the Company and Executive hereto agree as follows:

…

NON-REDEMPTION AGREEMENT

This Non-Redemption Agreement (this “Agreement”) is entered as of September [__], 2026 by and among Andretti Acquisition Corp. II, a Cayman Islands exempted company (the “Company”), Andretti Sponsor II LLC, a Delaware limited liability company (the “Sponsor”), and the undersigned investor (the “Investor”).

RECITALS

WHEREAS, the Sponsor currently holds Class B ordinary shares, par value $0.0001 per share, of the Company (the “Class B Ordinary Shares”) initially purchased in a private placement prior to the Company’s initial public offering (the “IPO” and such shares, the “Founder Shares”);

…

CERTAIN INFORMATION, IDENTIFIED BY, AND REPLACED WITH, A MARK OF “[**]” HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.

Execution Version

REGISTRATION RIGHTS AGREEMENT

ThisREGISTRATION RIGHTS AGREEMENT(this “Agreement”), dated as of September 4, 2026, is by and between Roth Principal Investments, LLC, a Delaware limited liability company (the “Investor”), and Fold Holdings, Inc., a Delaware corporation (the “Company”).

RECITALS

A. The Company and the Investor have entered into that certain Common Stock Purchase Agreement, dated as of the date hereof (the “Purchase Agreement”), pursuant to which the Company may issue, from time to time, to the Investor up to the lesser of (i) $25,000,000 in aggregate gross purchase price of newly issued shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), and (ii) the Exchange Cap (to the extent applicable under Section 3.5 of the Purchase Agreement), as provided for therein.

…

CERTAIN INFORMATION, IDENTIFIED BY, AND REPLACED WITH, A MARK OF “[**]” HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.

Execution Version

COMMON STOCK PURCHASE AGREEMENT

Dated as of September 4, 2026

by and between

FOLD HOLDINGS, INC.

and

ROTH PRINCIPAL INVESTMENTS, LLC

1251600166.v6

---

TABLE OF CONTENTS

Page

ARTICLE I DEFINITIONS		1
ARTICLE II PURCHASE AND SALE OF COMMON STOCK		2

…

---

Exhibit 10.4

Execution Version

September 6, 2026

Via E-mail

Kim Robison

Dear Kim:

As you are aware, WaFd, Inc. (the “Company”) plans to enter into an Agreement and Plan of Merger on or about September 6, 2026 (the “Merger Agreement”) with EverBank Financial Corp. (“EverBank”), pursuant to which EverBank will, subject to the terms and conditions set forth in the Merger Agreement, merge with and into the Company (the “Merger”), with the Company as the surviving corporation (hereinafter referred to in such capacity and together with EverBank, National Association, as the “Surviving Corporation”).  Reference is made to your Change of Control Agreement with the Company, dated as of January 24, 2018 (the “CIC Agreement”).

…

---

Exhibit 10.2

Execution Version

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is effective as of the Effective Date (as defined below), by and among WaFd, Inc. (the “Company”), WaFd Bank, the Washington-chartered bank subsidiary of the Company (including any successors thereto, the “Bank” and, together with the Company, “WaFd”), and Brent J. Beardall (“Executive”).

WHEREAS, pursuant to that certain Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”), by and between the Company and EverBank Financial Corp, a Delaware corporation (“EverBank”), EverBank will be merged with and into the Company;

WHEREAS, pursuant to the Merger Agreement, the Company shall take all such actions as may be required to cause the corporate name of the Surviving Corporation (as defined in the Merger Agreement) to be changed to EverBank Financial Corp. effective immediately following the Effective Time (as defined in the Merger Agreement);

…

---

Exhibit 10.3

Execution Version

September 6, 2026

Via E-mail

Brent J. Beardall

Dear Brent:

As you are aware, WaFd, Inc. (the “Company”) plans to enter into an Agreement and Plan of Merger on or about September 6, 2026 (the “Merger Agreement”) with EverBank Financial Corp. (“EverBank”), pursuant to which EverBank will, subject to the terms and conditions set forth in the Merger Agreement, merge with and into the Company (the “Merger”), with the Company as the surviving corporation (hereinafter referred to in such capacity and together with EverBank, National Association, as the “Surviving Corporation”).  Reference is made to your Change of Control Agreement with the Company, dated as of August 17, 2015 (the “CIC Agreement”).

…